Surgery for multiple endocrine neoplasia type 1-associated primary hyperparathyroidism
Authors:
- 13 July 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 97 (10) , 1528-1534
Abstract
Background: Surgery in patients with multiple endocrine neoplasia type 1 (MEN1)‐associated primary hyperparathyroidism (pHPT) is difficult as the condition it is caused by asymmetrical multiple gland hyperplasia. It is uncertain which operative procedure provides the best outcome with regard to long‐term normocalcaemia. Methods: All patients who had surgery for genetically confirmed MEN1‐associated pHPT between 1987 and 2009 were identified from a prospective database. Clinical data, operative procedures and outcome were analysed retrospectively. Results: A total of 47 patients were identified. Twenty‐three patients underwent total parathyroidectomy with thymectomy and autotransplantation (TPTX + AT), 11 patients subtotal parathyroidectomy (3–3·5 glands, SPTX) with thymectomy, and 13 patients selective gland excision (fewer than 3 glands, SGE). Rates of persistent disease, recurrent disease and permanent hypoparathyroidism after TPTX + AT were 4 per cent (1 patient), 4 per cent (1 patient) and 22 per cent (5 patients) respectively. Respective rates after SPTX were 0 per cent, 18 per cent (2 patients) and 45 per cent (5 patients), which were not statistically different from those following TPTX + AT. SGE resulted in persistent disease in 23 per cent (3 patients) and a significantly higher rate of recurrent disease (46 per cent, 6 patients; P = 0·004 versus TPTX, P = 0·210 versus SPTX), but permanent hypoparathyroidism did not occur. Conclusion: TPTX + AT and SPTX both seem adequate surgical procedures for the treatment of MEN1‐associated pHPT and are associated with fewer recurrences than SGE. Copyright © 2010 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.Keywords
This publication has 29 references indexed in Scilit:
- Prospective Study of Surgery for Primary Hyperparathyroidism (HPT) in Multiple Endocrine Neoplasia-Type 1 and Zollinger-Ellison SyndromeAnnals of Surgery, 2008
- Cutaneous Tumors in Patients with Multiple Endocrine Neoplasm Type 1 (MEN1) and Gastrinomas: Prospective Study of Frequency and Development of Criteria with High Sensitivity and Specificity for MEN1The Journal of Clinical Endocrinology & Metabolism, 2004
- Long-term results of less than total parathyroidectomy for hyperparathyroidism in multiple endocrine neoplasia type 1Surgery, 2002
- Primary Hyperparathyroidism in Patients with Multiple Endocrine Neoplasia Type 1: Comparison with Sporadic Parathyroid AdenomasHormone and Metabolic Research, 2001
- MEN1 gene mutations in 12 MEN1 families and their associated tumorsEuropean Journal of Endocrinology, 1998
- Late Outcome of 304 Consecutive Patients with Multiple Gland Enlargement in Primary Hyperparathyroidism Treated by Conservative SurgeryWorld Journal of Surgery, 1998
- Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related statesHuman Molecular Genetics, 1997
- Positional Cloning of the Gene for Multiple Endocrine Neoplasia-Type 1Science, 1997
- Subtotal Parathyroidectomy for Primary Chief Cell Hyperplasia of the Multiple Endocrine Neoplasia Type I SyndromeAnnals of Surgery, 1981
- Genetic aspects of adenomatosis of endocrine glandsThe American Journal of Medicine, 1954